Multifocal electroretinograms predict onset of diabetic retinopathy in adult patients with diabetes

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 2, 2011, Pages 772-777

  Harrison, Wendy W ^a   Bearse Jr , Marcus A ^a   Ng, Jason S ^b   Jewell, Nicholas P ^c   Barez, Shirin ^a   Burger, Dennis ^d   Schneck, Marilyn E ^a   Adams, Anthony J ^a  

^a University of California at Dominguez Hills   (United States)

^b SOUTHERN CALIFORNIA COLLEGE OF OPTOMETRY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; ELECTRORETINOGRAM; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; MALE; MUTIFOCAL ELECTRORETINOGRAM; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEX RATIO; VALIDATION PROCESS; ELECTRORETINOGRAPHY; INSULIN DEPENDENT DIABETES MELLITUS; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; RETINA; STATISTICAL MODEL; VALIDATION STUDY;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; ELECTRORETINOGRAPHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PREDICTIVE VALUE OF TESTS; RETINA; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 79953285176     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5931     Document Type: Article

References (43)

1. Huang ES, Basu A, O'Grady M, Capretta JC. Projecting the future diabetes population size and related costs for the U.S. Diabetes Care. 2009;32:2225-2229.
2. Centers for Disease Control and Prevention National diabetes fact sheet: general information and national estimates on diabetes in the United States. 2007. Atlanta, GA: U.S. Department of Health and Human Services; 2008.
3. Ferris F. Early photocoagulation in patients with either type I or type II diabetes. Trans Am Ophthalmol Soc. 1996;94:505-537.
4. Fong DS, Girach A, Boney A. Visual side effects of successful scatter laser photocoagulation surgery for proliferative diabetic retinopathy: a literature review. Retina. 2007;27:816-824.
5. Mohamed Q, Gillies MC, Wong TY. Management of diabetic retinopathy: a systematic review. JAMA. 2007;298:902-916.
6. Coyne KS, Margolis MK, Kennedy-Martin T, et al. The impact of diabetic retinopathy: perspectives from patient focus groups. Fam Pract. 2004;21:447-453.
7. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. Arch Ophthalmol. 1998;116.
8. Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, Sandvik L, Aagenaes O. Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study. Br Med J (Clin Res Ed). 1985;290: 811-815.
9. Lawson P, Champion M, Canny C, Kingsley R, White M, Kohner EM. Continuous subcutaneous insulin infusion does not prevent progression of preproliferative or proliferative retinopathy. Br J Ophthalmol. 1982;96:762-766.
10. Esteves JF, Kramer CK, Azevedo MJ, et al. Prevalence of diabetic retinopathy in patients with type 1 diabetes mellitus. Rev Assoc Med Bras. 2009;55:268-273.
11. Davis MD, Fisher MR, Gangnon RE, et al. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. Invest Oph-thalmol Vis Sci. 1998;39:233-252.
12. Henricsson M, Sellman A, Tyrberg M, Groop L. Progression to proliferative retinopathy and macular oedema requiring treatment: assessment of the alternative classification of the Wisconsin Study. Acta Ophthalmol Scand. 1999;77:218-223.
13. Conway BN, Miller RG, Klein R, Orchard TJ. Prediction of prolif-erative diabetic retinopathy with hemoglobin level. Arch Ophthal-mol. 2009;127:1494-1499.
14. Tight blood pressure control and risk of macrovascular and micro-vascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998;317:703-713.
15. Kohner EM, Stratton IM, Aldington SJ, Turner RC, Matthews DR. Microaneurysms in the development of diabetic retinopathy (UK-PDS 42). UK Prospective Diabetes Study Group. Diabetologia. 1999;42:1107-1112.
16. Durruty P, Carpentier C, Krause P, Garcia de los Rios M. [Evaluation of retinal involvement in type 2 diabetics with microalbumin-uria]. Rev Med Chil. 2000;128:1085-1092.
17. Wirta O, Pasternack A, Mustonen J, Laippala P, Lahde Y. Retinop-athy is independently related to microalbuminuria in type 2 diabetes mellitus. Clin Nephrol. 1999;51:329-334.
18. Ghirlanda G, Di Leo MA, Caputo S, Cercone S, Greco AV. From functional to microvascular abnormalities in early diabetic retinop-athy. Diabetes Metab Rev. 1997;13:15-35.
19. Shirao Y, Kawasaki K. Electrical responses from diabetic retina. Prog Retin Eye Res. 1998;17:59-76.
20. Tzekov R, Arden GB. The electroretinogram in diabetic retinopa-thy. Surv Ophthalmol. 1999;44:53-60.
21. Barber AJ. A new view of diabetic retinopathy: a neurodegenera-tive disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27:283-290.
22. Fortune B, Schneck ME, Adams AJ. Multifocal electroretinogram delays reveal local retinal dysfunction in early diabetic retinopathy. Invest Ophthalmol Vis Sci. 1999;40:2638-2651.
23. Han Y, Schneck ME, Bearse MA., et al. Formulation and evaluation of a predictive model to identify the sites of future diabetic retinopathy. Invest Ophthalmol Vis Sci. 2004;45:4106-4112.
24. Han Y, Bearse MA Jr., Schneck ME, Barez S, Jacobsen CH, Adams AJ. Multifocal electroretinogram delays predict sites of subsequent diabetic retinopathy. Invest Ophthalmol Vis Sci. 2004;45:948-954.
25. Ng JS, Bearse MA, Schneck ME, Barez S, Adams AJ. Local diabetic retinopathy prediction by multifocal ERG delays over 3 years. Invest Ophthalmol Vis Sci. 2008;49:1622-1628.
26. Bearse MA, Adams AJ, Han Y, et al. A multifocal electroretino-gram model predicting the development of diabetic retinopathy. Prog Retin Eye Res. 2006;25:425-448.
27. Hood D, Li J. A technique for measuring individual multifocal ERG records. In: Yager D, ed. Non-invasive Assessment of the Visual System: Trends in Optics and Photonics. Washington, DC: Optical Society of America; 1997:33-41.
28. Harrison WW, Bearse MA, Ng JS, Barez S, Schneck ME, Adams AJ. Reproducibility of the mfERG between instruments. Doc Ophthalmol. 2009;119:67-78.
29. Jewell NP. Statistics for Epidemology. Boca Raton, FL: Chapman and Hall; 2004.
30. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics. 1988;44:1049-1060.
31. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982; 143:29-36.
32. Burman P. A comparative study of ordinary cross-validation, v-fold cross validation and the repeated learning-testing methods. Biometrika. 1989;76:503-514.
33. Kohavi R. A study of cross-validation and bootstrap for accuracy estimation and model select in. In: Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence. Menlo Park, CA: International Joint Conference on Artificial Intelligence; 1995:1137-1143.
34. Stitt AW, Gardiner TA, Archer DB. Histological and ultrastructural investigation of retinal microaneurysm development in diabetic patients. Br J Ophthalmol. 1995;79:362-367.
35. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of diabetic retinopathy, XIV: ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol. 1994;112:1217-1228.
36. Churchill J, Ruppe R, Smaldone A. Use of continuous insulin infusion pumps in young children with type 1 diabetes: a systematic review. J Pediatr Health Care. 2009;23:173-179.
37. National Institutes of Health. Fact Sheet: Type 1 Diabetes. www.nih.gov/about/researchresultsforthepublic/Type1Diabetes.pdf. Updated January 2010. Accessed November 16, 2010.
38. Fong DS, Aiello L, Gardner TW, et al. Retinopathy in diabetes. Diabetes Care. 2004;27(suppl 1):S84-S87.
39. Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy, XXII: the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology. 2008;115:1859-1868.
40. Stratton IM, Kohner EM, Aldington SJ, et al. UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia. 2001;44: 156-163.
41. Cai X, Wang F, Ji L. Risk factors of diabetic retinopathy in type 2 diabetic patients. Chin Med J. 2006;119:822-826.
42. Berger V. Does the Prentice criterion validate surrogate end-points? Stat Med. 2004;23:1571-1578.
43. Cunha-Vaz JG, Bernardes R. Nonproliferative retinopathy in diabetes type 2: initial stages and characterization of phenotypes. Prog Retin Eye Res. 2005;24:355-377.